Record overview
Status and phase
Status: COMPLETED
Phase: PHASE1, PHASE2
Sponsor: Gritstone bio, Inc.
Condition: Non Small Cell Lung Cancer, Colorectal Cancer, Gastroesophageal Adenocarcinoma, Urothelial Carcinoma
NCT03639714
A Study of a Personalized Neoantigen Cancer Vaccine
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: stale_update_signal
Results signal: Completed No Results Found Signal
Operational burden: rare_population_signal | strict_eligibility_signal
Stopped reason
Context when available
No stop reason available in the current public record.